As a hypothesis for the relationship between estrogen deficiency, bone loss, and inflammation in osteoporosis, it has been suggested that pro-inflammatory cytokines, such as interleukin-1 (IL-1), tumor necrosis factor-alpha (TNF-α), and IL-6, are the primary mediators of accelerated bone loss during menopause [42]. This evidence concerns the gene TNF and osteoporosis.